Overview of DOT Oral Fluid Testing Program

Purpose and Importance of the Oral Fluid Drug Testing Program

The U.S. Department of Transportation (DOT) has implemented oral fluid drug testing as an alternative to urine drug testing for safety-sensitive transportation employees. The primary objective of this program is to ensure public safety by maintaining a drug-free workplace in regulated industries, such as aviation, highway, railroad, transit, pipeline, and maritime sectors. By offering oral fluid testing, the DOT provides employers with additional flexibility and options for drug testing, particularly in scenarios where urine collection may not be practical.

Oral fluid drug testing enhances the integrity and efficiency of the testing process while protecting employee privacy. It provides a less invasive and more direct observation method, which minimizes the potential for specimen adulteration or substitution.

Regulatory Background

DOT-regulated drug testing programs operate under the authority of 49 CFR Part 40, "Procedures for Transportation Workplace Drug Testing Programs." The program is overseen by the Office of Drug and Alcohol Policy and Compliance (ODAPC) in coordination with DOT agencies, including:

• Federal Aviation Administration (FAA)
• Federal Motor Carrier Safety Administration (FMCSA)
• Federal Railroad Administration (FRA)
• Federal Transit Administration (FTA)
• Pipeline and Hazardous Materials Safety Administration (PHMSA)
• United States Coast Guard (USCG)

On May 2, 2023, DOT published a final rule in the Federal Register [88 FR 27596], effective June 1, 2023, authorizing oral fluid specimen testing. However, oral fluid testing cannot commence until at least two Health and Human Services (HHS)-certified laboratories for oral fluid testing are operational.

Roles and Responsibilities

Collectors

Collectors play a critical role in ensuring the integrity and accuracy of the drug testing process. Their primary responsibilities include:

• Conducting the collection process in strict adherence to 49 CFR Part 40 regulations.
• Ensuring privacy, security, and proper handling of oral fluid specimens.
• Accurately completing the Federal Drug Testing Custody and Control Form (CCF).
• Maintaining up-to-date training and proficiency in oral fluid collection procedures.

Employers

Employers are responsible for maintaining a compliant drug testing program by:

• Deciding on the specimen type (urine or oral fluid) for different testing situations.
• Providing clear "standing orders" to collectors regarding specimen types.
• Ensuring collectors have access to correct laboratory information and required materials.
• Maintaining communication with the Designated Employer Representative (DER) for decision-making during testing issues.

Employees (Donors)

Employees subject to DOT drug testing must:

• Comply with identification and collection procedures.
• Follow the collector’s instructions throughout the testing process.
• Understand their rights and responsibilities during the collection.

Key Benefits of Oral Fluid Testing

1. Improved Collection Integrity: Direct observation minimizes tampering and substitution risks.
2. Less Invasive Process: Oral fluid collection is simpler and more comfortable for employees.
3. Faster Detection Window: Oral fluid testing can detect recent drug use more effectively than urine testing.
4. Flexible Collection Options: Suitable for a wide range of testing scenarios, including post-accident or on-site collections.

Conclusion

The DOT Oral Fluid Testing Program is designed to enhance workplace safety, improve collection efficiency, and maintain the highest standards of integrity. Understanding the roles and responsibilities of collectors, employers, and employees ensures successful implementation and compliance with DOT regulations. This program plays a vital role in achieving the DOT's safety goals by preventing substance abuse in safety-sensitive industries.